Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Boston Scientific

S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy Points

S&P 500 components Fortinet and Boston Scientific are among five stocks to watch near buy points as 2024 comes to a close.

Investors Business Daily

Dow Jones Futures Fall: Small Caps Lead As SoundHound Surges; Nvidia At Key Level

Small caps rose with the major indexes steady Thursday. Nvidia is at key levels. SoundHound, Rocket Lab and other heat stocks soared.

Investors Business Daily

Boston Scientific, IBD Stock Of The Day, Has Surged 57% In 2024. This Is Why There's More Upside.

Boston Scientific has soared this year and analysts are hiking price targets for the stock heading into 2025.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Are Wall Street Analysts Bullish on Boston Scientific Stock?

Boston Scientific has significantly outperformed the broader market over the past year, and analysts maintain a very bullish view on its outlook.

Barchart

Up 45% YTD, Should You Buy This Outperforming Healthcare Stock?

Boston Scientific shows impressive growth in Q3 results, garnering bullish analyst support despite clinical trial setbacks.

Barchart

Boston Scientific's Rockstar Segment Just Fumbled — And So Did Its Shares

Boston Scientific stock pulled back from its run at a record high on Wednesday despite reporting a sweeping third-quarter beat.

Investors Business Daily

Earnings Preview: What To Expect from Boston Scientific's Report

With Boston Scientific gearing up to release its third-quarter earnings later this month, analysts expect double-digit earnings growth.

Barchart

Read news from The Economist, FT, and more,
with one subscription

3 'Strong Buy' Stocks to Grab Now for More Gains

For investors looking to add some high-potential stocks to their portfolio, here are three top-rated opportunities to consider now.

Barchart

Is Boston Scientific Stock Outperforming the Nasdaq?

Boston Scientific has outperformed the Nasdaq Composite over the past year, and analysts remain bullish on the stock’s prospects.

Barchart

'I'm on morphine patches every day': Woman still waiting for vaginal mesh removal four years later

‘I used to walk everywhere, but now I just potter around the house. I no longer walk to the shops,’ June Dunne tells Maya Oppenheim

The Independent UK

Women harmed by vaginal mesh in England get payout

The amount of the financial settlement has not been made public, although it is expected millions have been paid out

Evening Standard

140 women win payouts for vaginal mesh complications

Women claimed the implants caused infection, bleeding, chronic pain, bladder and bowel perforations, and problems urinating

The Independent UK

140 women in England receive payout for vaginal mesh implant complications

Settlement from first successful group claim in England expected to total millions of pounds, but size of payments unknown

The Guardian - UK

What Are Wall Street Analysts' Target Price for Boston Scientific Stock?

Boston Scientific has outperformed the broader market over the past year, and analysts remain bullish about the stock’s prospects.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

How Boston Scientific's digital and IT boss upgraded her team from order takers to strategic thinkers

The $110 billion medical devices company now has a digital leader who sits on the executive management board of every division, every region, and every business function.

Investors Business Daily

Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review

The stock market remained split, with small caps leading and the Nasdaq tumbling, led by Google and Tesla.

Investors Business Daily

Boston Sci Slumps After One Key Segment Drives Its Second-Quarter Beat

Boston Scientific stock slumped Wednesday despite a "big organic revenue beat" driven by strong electrophysiology sales, one analyst said.

Barchart

Boston Scientific's Quarterly Earnings Preview: What You Need to Know

Boston Scientific is expected to report its second-quarter earnings results this month, and Wall Street analysts expect a single-digit profit growth.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover

Silk stock skyrocketed Tuesday after Boston Scientific agreed to buy the medical devices company for $1.16 billion.

Barchart

Is Boston Scientific Stock Outperforming the S&P 500?

Boston Scientific recently reached an all-time high, outperforming the S&P 500 Index, with Wall Street analysts remaining bullish about the stock’s prospects.

Barchart

Boston Scientific Stock: Is Wall Street Bullish or Bearish?

Boston Scientific has significantly outperformed the broader market YTD, and Wall Street analysts are still bullish about the stock’s prospects.

Investors Business Daily

The Bullish First-Quarter Report That Helped Boston Scientific Break Out — Twice

Boston Scientific made a bullish move Wednesday morning, topping two buy points on a solid first-quarter report.

Barchart

3 Safe Haven Stocks to Own in an Unpredictable Market

Even though 2024 kicked off strong, recent macroeconomic uncertainties highlight the need for resilient investments. These three “safe haven” stocks are worth considering for hedging against the market downswings.

Investors Business Daily

Boston Scientific Surges To A Record On Its 'Impressive' First-Quarter Guidance

Boston Scientific's first-quarter sales guidance is "impressive," an analyst said Wednesday as BSX stock hit a record high.

Investors Business Daily

Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts

Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.